checkAd
    Connect Biopharma Holdings Aktie
    1,7100
     
    USD
    +10,32 %
    +0,1600 USD
    Letzter Kurs 01.06.24 Nasdaq
    1,6500
     
    USD
    2.500 STK
    Geldkurs 31.05.24
    1,7900
     
    USD
    100 STK
    Briefkurs 31.05.24
    ISIN: US2075231017 · WKN: A2QR0E · SYM: CNTB · Kaiman-Inseln

    Neueste Nachrichten

    Connect Biopharma Presents Late-Breaking Abstract at the American Thoracic Society 2024 International Conference on the Positive Rademikibart Data from its Global Phase 2b in Patients with Moderate-to-Severe Asthma
    22.05.24 · globenewswire · Connect Biopharma Holdings
    Connect Biopharma to Present a Late-Breaking Abstract at the American Thoracic Society (ATS) 2024 International Conference on the Positive Results from the Global Phase 2b Trial of Rademikibart in Patients with Moderate-to-Severe Asthma
    07.05.24 · globenewswire · Connect Biopharma Holdings
    Connect Biopharma Reports Full Year 2023 Financial Results and Provides Business Update
    16.04.24 · globenewswire · Connect Biopharma Holdings
    Connect Biopharma to Participate in H.C. Wainwright 2ⁿᵈ Annual Autoimmune & Inflammatory Disease Virtual Conference
    19.03.24 · globenewswire · Connect Biopharma Holdings
    Connect Biopharma Appoints Industry Veteran James Huang to Board of Directors
    12.02.24 · globenewswire · Connect Biopharma Holdings
    Connect Biopharma and Simcere Announce Exclusive Licensing and Collaboration Agreement in Greater China
    21.11.23 · globenewswire · Connect Biopharma Holdings
    Connect Biopharma Announces Positive Long-Term Data from the China Pivotal Trial of Rademikibart in Patients with Moderate-to-Severe Atopic Dermatitis
    21.11.23 · globenewswire · Connect Biopharma Holdings
    Connect Biopharma to Announce Long-Term Data from the China Pivotal Trial of Rademikibart in Patients with Moderate-to-Severe Atopic Dermatitis on November 21, 2023
    20.11.23 · globenewswire · Connect Biopharma Holdings
    Connect Biopharma Reports First Half 2023 Financial Results and Provides Business Update
    12.09.23 · globenewswire · Connect Biopharma Holdings
    Connect Biopharma Announces Receipt of NASDAQ Deficiency Notice Regarding Minimum Bid Price Requirement
    12.09.23 · globenewswire · Connect Biopharma Holdings
    Connect Biopharma to Participate in Upcoming September Investor Conferences
    25.08.23 · globenewswire · Connect Biopharma Holdings
    Connect Biopharma Presented Additional Data from its Atopic Dermatitis Pivotal Trial in China at the 2023 World Congress of Dermatology
    10.07.23 · globenewswire · Connect Biopharma Holdings